WNT subgroup medulloblastomas are defined by activation of the Wnt/Wg signalling pathway, associated with nuclear accumulation of the β‐catenin protein, CTNNB1 mutation and monosomy of chromosome 6.6, 16. Here, CTNNB1 is linked to medulloblastoma.